These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9295927)

  • 41. Calcium--a neglected key factor in arteriosclerosis. The pathogenic role of arterial calcium overload and its prevention by calcium antagonists.
    Fleckenstein-Grün G; Fleckenstein A
    Ann Med; 1991; 23(5):589-99. PubMed ID: 1756029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium channel blockers and coronary atherosclerosis: from the rabbit to the real world.
    Waters D; Lespérance J
    Am Heart J; 1994 Dec; 128(6 Pt 2):1309-16. PubMed ID: 7977012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A free radical mechanism for inhibition of arteriosclerosis development with calcium antagonists].
    Andrzejak R; Goch JH; Jurga M
    Postepy Hig Med Dosw; 1995; 49(5):645-59. PubMed ID: 8677227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium-channel antagonists for prevention of atherosclerosis.
    Borcherding SM; Meeves SG; Klutman NE; Howard PA
    Ann Pharmacother; 1993 Jan; 27(1):61-7. PubMed ID: 8431624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Regression of coronary atherosclerosis evaluated by angiography. A review of principal trials and critical study].
    Castaigne A; Albo C; Pham I; Saal JP; Verschuren P
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():31-7. PubMed ID: 8215778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atherogenesis, calcium and calcium antagonists.
    Henry PD
    Am J Cardiol; 1990 Dec; 66(21):3I-6I. PubMed ID: 2256467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The calcium antagonists in the 1990s. An overview.
    Oparil S; Calhoun DA
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):396S-405S. PubMed ID: 1910636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Calcium, calcium antagonists and atherogenesis].
    Desgranges C; Larrue J
    Rev Prat; 1988 Nov; 38(26):1912-6. PubMed ID: 3065920
    [No Abstract]   [Full Text] [Related]  

  • 49. [The pharmacological rationale for the development of a calcium antagonist in the prevention of damage to the arterial wall].
    Paoletti R
    Ann Ital Med Int; 1995 Oct; 10 Suppl():73S. PubMed ID: 8562271
    [No Abstract]   [Full Text] [Related]  

  • 50. Retardation and arrest of progression or regression of coronary artery disease: a review.
    Vos J; de Feyter PJ; Simoons ML; Tijssen JG; Deckers JW
    Prog Cardiovasc Dis; 1993; 35(6):435-54. PubMed ID: 8497659
    [No Abstract]   [Full Text] [Related]  

  • 51. Creation of atheromatous plaques in experimental animals.
    Dreesen RG; Becker GJ; Jackson VP
    Radiol Technol; 1987; 58(6):513-6. PubMed ID: 3303116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of calcium antagonists in the treatment of atherosclerosis].
    Aron A; Aron L
    Harefuah; 1993 Aug; 125(3-4):90-3. PubMed ID: 8225086
    [No Abstract]   [Full Text] [Related]  

  • 53. Photodynamic diagnosis and treatment for atherosclerosis by an endoscopic approach.
    Hayashi J; Saito T; Aizawa K
    Diagn Ther Endosc; 1999; 5(3):191-5. PubMed ID: 18493502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Model experiments on anticalcinotic and antiarteriosclerotic arterial protection with calcium antagonists.
    Fleckenstein A
    J Mol Cell Cardiol; 1987 May; 19 Suppl 2():109-21. PubMed ID: 3305965
    [No Abstract]   [Full Text] [Related]  

  • 55. Atheromatous coronary artery disease. 1. Clinical and experimental observations.
    WOLFFE JB
    Trans Am Coll Cardiol; 1951; 1():122-34. PubMed ID: 13005581
    [No Abstract]   [Full Text] [Related]  

  • 56. Exercise training and regression of coronary atheromatous plaques.
    Čulić V
    Eur J Prev Cardiol; 2024 Mar; 31(4):e8. PubMed ID: 37379581
    [No Abstract]   [Full Text] [Related]  

  • 57. [Progression and regression of the atheromatous plaque].
    Strano A; Novo S; Abrignani MG
    Cardiologia; 1989 Nov; 34(11):905-7. PubMed ID: 2631981
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevention of radiation-induced atheromatous plaque formation by prednisolone. A morphologic exploration.
    Vos J; Dijk F; Aarnoudse MW; Lamberts HB
    Cell Biol Int Rep; 1981 May; 5(5):466. PubMed ID: 7237574
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of the healing effect of mesoglicanum (hexosaminoglycan sulfate) on experimental atheromatous lesions in the rabbit. Ultrastructural observations].
    Palmieri B; Di Blasio P; Magliocca R
    Boll Chim Farm; 1981 Jul; 120(7):400-6. PubMed ID: 7317166
    [No Abstract]   [Full Text] [Related]  

  • 60. The Resorption of Arterial Atheromatous Deposits in Wasting Disease.
    Wilens SL
    Am J Pathol; 1947 Sep; 23(5):793-804. PubMed ID: 19970960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.